Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Pamela Crilley"'
Autor:
Pamela Crilley
Publikováno v:
Oncology Times. 40:1
Autor:
Stuthi Perimbeti, Kristine Ward, Kevin Ye Hou, Pamela Crilley, Sabarina Ramanathan, Michael Styler, Adonas Woodard, David Topolsky, Daniel Kyung
Publikováno v:
Blood. 132:5889-5889
Introduction: Case reports have suggested that there is an increased risk of hematological malignancies with sickle cell disease (SCD). We aimed to investigate the prevalence and mortality of select hematological malignancies, including: acute myeloi
Autor:
Kristine Ward, Qian Wang, Sabarina Ramanathan, Michael Styler, Adonas Woodard, Pamela Crilley, Stuthi Perimbeti, Kevin Ye Hou, Daniel Kyung
Publikováno v:
Blood. 132:5886-5886
Introduction: Sickle cell disease (SCD) is a chronic and debilitating disorder that affects approximately 100,000 Americans and results in the development of significant complications, leading to high numbers of hospitalizations, healthcare cost and
Autor:
Jonathan D. Powell, Pamela Crilley, Nancy D. Rossiter, Carol Ann Huff, Jeanne Kowalski, Hua Ling Tsai, Ephraim J. Fuchs, Richard F. Ambinder, William Matsui, Mary S. Leffell, Javier Bolaños-Meade, Richard J. Jones, Ivan Borrello, Lawrence E. Morris, Yvette L. Kasamon, Paul O'Donnell, Leo Luznik, Robert A. Brodsky, Lode J. Swinnen
Publikováno v:
Biology of Blood and Marrow Transplantation. 16(4):482-489
Although some reports have found an association between increasing HLA disparity between donor and recipient and fewer relapses after allogeneic blood or marrow transplantation (BMT), this potential benefit has been offset by more graft-versus-host d
Autor:
Pamela Crilley
Publikováno v:
Oncology Times. 40:1
Autor:
David Topolsky, Kristine Ward, Erin R. Reichenberger, Nicole Simpkins, Pamela Crilley, Robert J. Schwartzman, Guillermo M. Alexander, Noah Lindenberg
Publikováno v:
CNS Neuroscience & Therapeutics. 15:118-127
High dose cyclophosphamide (HDC) has been successfully used for the treatment of a variety of autoimmune diseases. In this study, we sought to determine whether the use of high dose cyclophosphamide provided stabilization of relapsing remitting MS (R
Autor:
S Hoch, Isadore Brodsky, A. Pradhan, Pamela Crilley, David Topolsky, Michael Styler, Douglas E. Gladstone, A Huppert, Ann A. Prestrud
Publikováno v:
Lupus. 11:405-410
Cytotoxic therapy is a cornerstone for patients with severe systemic lupus erythematosus (SLE). High-dose cyclophosphamide, 200 mg/kg, can induce a complete remission without the need for stem cell rescue in patients with autoimmune illnesses. Here w
Publikováno v:
Gastrointestinal Endoscopy. 53:355-359
VOLUME 53, NO. 3, 2001 GASTROINTESTINAL ENDOSCOPY 355 ling for myelofibrosis with myeloid metaplasia. The patient’s medical history included a splenectomy and cerebrovascular accident secondary to atherosclerosis. Eighteen days after transplant the
Autor:
Daniela M. Albu, Maurie Markman, Diane Denny, Pamela Crilley, David Topolsky, Ankur R. Parikh, Scott Hartman, Brandon Bosch
Publikováno v:
Blood. 128:5990-5990
BACKGROUND : In patients with hematologic malignancies symptoms related to the disease and its treatment remain a major problem in patient care. With the advent of new treatment including immunotherapy and targeted therapies the potential for prolong
Autor:
Tiffany Pompa, Adonas Woodard, Maneesh Jain, Jeurkar Chet, Kristine Ward, Michael Styler, Maelys Amat, Pamela Crilley, Dave Topolsky, Mark Maddox
Publikováno v:
Blood. 128:2360-2360
Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant disorder characterized by the asymptomatic presence of a monoclonal protein. It is defined by an M protein < 3 gm/dl, less than 10% clonal plasma cells in the bone marrow, an